Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies - Achiron, Anat; Mandel, Mathilda; Dreyer-Alster, Sapir; Harari, Gil; Magalashvili, David; Sonis, Polina; Dolev, Mark; Menascu, Shay; Flechter, Shlomo; Falb, Rina; Gurevich, Michael (Therapeutic advances in neurological disorders, 2021)
Keywords: Cell number; Cladribine; Coronaviruses; COVID-19 vaccines; Dosage; Humoral immunity; Immune response; Immune response (humoral); Immunoglobulin G; Lymphocytes; Monoclonal antibodies; mRNA; Multiple sclerosis; Original Research; Patients; Serology; Severe acute respiratory syndrome coronavirus 2; Spike protein; Vaccination; Vaccines; COVID-19; SARS-COV-2 IgG; humoral immune response; multiple sclerosis; mRNA vaccine